The State of Ohio has become one of the many states that have fallen victim to PBMs' abusive revenue tactics, as detailed in an audit report finding that the state's PBMs — OptumRx and Caremark — charged the state a spread of 31% on generic... Read More
Plan Sponsors should be aware of a few recent developments that lead to high gross and net drug prices. First, the White House recently withdrew a Notice of Proposed Rule Making (NPRM) that would have altered the entire drug marketplace. The NPRM... Read More
Frier Levitt recently helped an Oklahoma-based pharmacy overturn all findings from a PBM audit after re-opening the audit which had been closed for over a year. During the time of the audit, the PBM maintained that it did not receive the... Read More
Frier Levitt recently assisted an independent pharmacy with an audit after a PBM alleged that several drugs showed a shortfall of inventory. Frier Levitt worked with the pharmacy and reviewed all records of the drug purchases, and provided proof of... Read More
